4//SEC Filing
SOLAZYME INC 4
Accession 0001555667-16-000069
CIK 0001311230operating
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 6:38 PM ET
Size
5.2 KB
Accession
0001555667-16-000069
Insider Transaction Report
Form 4
SOLAZYME INCSZYM
Licari Peter
EVP, Research & Development
Transactions
- Sale
Common Stock
2016-03-10$1.64/sh−1,562$2,557→ 219,281 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was designed to cover tax withholding obligations in connection with the concurrent vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.68, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
SOLAZYME INC
CIK 0001311230
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311230
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 6:38 PM ET
- Size
- 5.2 KB